HSCS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HeartSciences Inc (HSCS) is not a good buy for a beginner, long-term investor at this time. The technical indicators suggest a bearish trend, the financial performance is weak with declining net income and EPS, and there are no strong positive catalysts or trading signals to support a buy decision. The stock's oversold RSI and potential minor short-term gains do not align with the user's long-term investment strategy.
The stock is in a bearish trend with MACD negatively expanding, RSI at 19.188 indicating oversold conditions, and moving averages showing weakness (SMA_200 > SMA_20 > SMA_5). Support levels are at 2.359 and 2.245, while resistance levels are at 2.725 and 2.839. The stock has a 60% chance to gain 0.83% in the next week but remains weak overall.
HeartSciences' MyoVista Insights™ platform received Epic Toolbox designation, enhancing its competitiveness in the ECG management system sector and supporting integration with hospital information systems.
is also down by -1.79%. Additionally, there are no significant hedge fund or insider trading trends, and financial performance remains weak.
In Q3 2026, revenue remained at 0 with no growth YoY. Net income dropped by -21.73% YoY to -1,985,208, and EPS declined by -75.49% YoY to -0.63. Gross margin increased to 59.06 but did not show YoY growth.
No analyst rating or price target data is available for this stock.
